APA

Stühmer T., Zöllinger A., Siegmund D., Chatterjee M., Grella E., Knop S., Kortüm M., Unzicker C., Jensen M. R., Quadt C., Chène P., Schoepfer J., García-Echeverría C., Einsele H., Wajant H. & Bargou R. C. (20080911). Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma. : Leukemia.

Chicago

Stühmer T, Zöllinger A, Siegmund D, Chatterjee M, Grella E, Knop S, Kortüm M, Unzicker C, Jensen M R, Quadt C, Chène P, Schoepfer J, García-Echeverría C, Einsele H, Wajant H and Bargou R C. 20080911. Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma. : Leukemia.

Harvard

Stühmer T., Zöllinger A., Siegmund D., Chatterjee M., Grella E., Knop S., Kortüm M., Unzicker C., Jensen M. R., Quadt C., Chène P., Schoepfer J., García-Echeverría C., Einsele H., Wajant H. and Bargou R. C. (20080911). Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma. : Leukemia.

MLA

Stühmer T, Zöllinger A, Siegmund D, Chatterjee M, Grella E, Knop S, Kortüm M, Unzicker C, Jensen M R, Quadt C, Chène P, Schoepfer J, García-Echeverría C, Einsele H, Wajant H and Bargou R C. Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma. : Leukemia. 20080911.